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Abstract
We use information from Hawaii Medicaid data for individuals who have at least one
FASD-related condition. The total spending for these individuals between 2011 and
2015 was $460,515,584. Of that total, more than $32 million is directly associated
with FASD-related visits/codes. We find that the average FASD-related visit costs
$121, which is more expensive than the average medicaid visit. We also find that the
frequency of FASD-related visits increases with age. We find evidence that the number
of initial conditions is positively associated with the number of visits and accumulated
medical costs and that 20% of the patients are responsible for 85.85% of the total
spending.
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1 What are FASDs?
Fetal alcohol spectrum disorders (FASDs), a collection of permanent yet preventable develop-
mental disabilities and birth defects resulting from prenatal alcohol exposure, are associated
with substantial costs (Popova et al., 2017). FASDs have been conservatively estimated
to affect one in 20 U.S. children (May et al., 2018). However, as explained in Chasnoff
et al. (2015), many FASD cases are often missed or misdiagnosed because of unknown or
unconfirmed prenatal alcohol exposure, lack of universal diagnostic guidelines, and a high
prevalence of comorbidities. Over four hundred co-morbid conditions have been found to
occur among individuals with FASD (Popova et al., 2016). This high number of comorbid
conidtions is due to the potent teratogenic effects of alcohol, which creates potential for
abnormal fetal development and produces lifelong health consequences Hong and Krauss
(2017). Further, people living with FASD present with wide-ranging needs spanning across
systems of care including social services, criminal justice, education, medicine, and mental
health (Jirikowic et al., 2010). Sizeable financial and social impacts related to FASDs have
cut across global, regional, and local communities (Lange et al., 2017).
1.1 FASDs are preventable
FASDs are preventable if a fetus is not exposed to alcohol. Therefore, prevention efforts tar-
get alcohol consumption among people who are or could become pregnant. One cost-effective
method for FASD prevention is alcohol screening and brief intervention (SBI). The U.S. Pre-
ventive Services Task Force (USPSTF) recommends alcohol SBI for unhealthy alcohol use as
a population-wide clinical preventive service for all adults in primary care, including those
who are or could become pregnant (O’Connor, Perdue, Senger, Rushkin, Patnode, Bean,
& Jonas, 2018). Despite sufficient efficacy evidence, overall uptake of alcohol SBI in clin-
ical settings lags (Babor et al., 2007; Désy and Perhats, 2008; Lewis et al., 2014). Local
efforts to address challenges associated with alcohol SBI implementation may provide scal-
able information that can be used to advance regional and national FASD prevention efforts
(Rieckmann et al., 2018).
Since 2007, the State of Hawaii has been addressing FASD prevention, including training
and implementation efforts, to increase maternal screening for alcohol use during pregnancy.
However, inadequate infrastructure and limited resources have impeded progress. Policy-
level changes to improve universal alcohol SBI, particularly among pregnant women, have
been highlighted as necessary to build a strategic, state-wide comprehensive FASD prevention
plan (Onoye and Thompson, 2017).
2 Method
2.1 How do we quantify costs?
The goal of our analysis is to understand how FASD is associated with health care visits
and spending for Hawaii Medicaid recipients. In order to quantify costs associated with
FASDs, we examine Hawaii Medicaid data with visits from 2011-2015. We use inclusion
criteria of patients less than 19 years old with one or more FASD-related visit. To identify
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these visits, we rely on diagnosis codes from the American Academy of Pediatrics, who has a
comprehensive list of diagnoses associated with FASDs from both ICD-9 and ICD-10.1 For
each visit, we have diagnosis code, procedure code, amount (in $) billed, and amount (in $)
paid.
If an individual had an FASD-related diagnosis, then we have that person’s universe of
visits and costs for the 5 years between 2011 and 2015 during which the individual was
under the age of 19. For the rest of the paper, we refer to the first FASD-related diagnosis
occurring in the available data for each individual (i.e., inclusion criteria of an FASD-related
condition) as ”initial FASD diagnosis.”
It is important to note that the period for inclusion for initial diagnosis of an FASD-
related condition is between 2009 and 2015. While all the analysis is broadly interested in
the visits and expenditures for FASDs, there are only 10 people who have an initial diagnosis
of fetal alcohol syndrome (FAS; code 76071). This is unsurprising as FAS is only a small
subset of the FASD umbrella and conditions under this umbrella are often undiagnosed.
Annualized results are based on 13,557 which is the average number of individuals across
the five years in our sample. Our sample has approximately 9% of Medicaid beneficiaries
ages 0-18. In total, we have records for 18,711 individuals between the ages of 0 and 18. Of
those, we have 1,198 individuals with 0 expenses after merging because these individuals do
not have a cohort number. Therefore our analysis will focus on the 17,513 individuals who
we observe having at least one medical visit during the study period of 2011-2015.
Given our goal in this analysis of understanding the costs associated with FASDs in the
Hawaii Medicaid population, we approach the question by examining the overall spending
of people who meet our initial inclusion criteria as well as focus on specific diagnoses that
are most likely to be linked to FASD.
3 Summary statistics
Below, we list some basic descriptive statistics regarding the characteristics of the Medicaid
recipients for whom we have data. Our sample is 60.7% male and 39.3% female. The largest
three groups by race are Native Hawaiian (23.2%), white (22.2%), and Filipino (15.1%).
In Table 3, we show the distribution of visits and spending for all visits and FASD-related
visits. In Table 4, we decompose our sample by the number of original diagnoses identified
for each individual. We see that the majority of individuals (82.7%) have one FASD-related
diagnosis, and only 750 (4.3%) with 3 or more diagnoses.
3.1 Hawaii’s childhood Medicaid population
In FY2012, Hawaii Medicaid covered 107,000 children in Hawaii, with annual costs per child
averaging $2,015 (American Academy of Pediatrics, 2017). At the end of calendar year 2015,
Hawaii Medicaid had 151,173 beneficiaries 0-18 years of age. In our sample of individuals
with a FASD-related diagnosis, for the same calendar year, 13,167 individuals are included.
Therefore, our sample represents 8.8% of Hawaii’s childhood Medicaid population.
1See Appendix 1 for a list of codes included as inclusion criteria.
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Table 1: Number of patients by race and gender
Race Female Male Total
Native Hawaiian 1,435 2,624 4,059
White 1,484 2,407 3,891
Filipino 1,031 1,672 2,703
Pacific Islander 492 846 1,338
Other Asian 898 1,451 2,349
Other 819 1,217 2,036
Unknown 492 645 1,137
Total 6,651 10,862 17,513
Table 2: Charges by visit and annually per individual
Year M per visit SD per visit M total SD total
Charges by year at the individual level
2011 110.91 307.28 6,502.28 32,847.55
2012 108.77 336.69 5,996.10 46,227.22
2013 110.11 394.79 6,867.62 42,452.16
2014 110.63 423.27 7,385.58 43,999.51
2015 95.69 342.00 7,192.87 55,439.74
Average 107.30 364.71 5,427.15 40,149.71
FASD charges by year at the individual level
2011 152.07 658.87 1,377.14 7,308.036
2012 130.09 536.11 1,328.03 7,027.83
2013 113.70 532.16 1,184.94 6,316.76
2014 110.42 442.65 1,355.57 9,595.73
2015 105.18 709.87 1,331.67 7,885.14
Average 121.37 582.84 1,313.77 7,723.91
Notes: M per visit refers to the average number of visits at the individual level, SD per visit
refers to the standard deviation of number of visits at the individual level. M total refers to
average total spending per year, and SD total refers to the standard deviation of the average
total spending.
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3.2 How often did people visit the doctor?
In the table below, we examine the distribution of overall visits, FASD-related visits, and
the corresponding spending. We find that, on average, the individuals in our sample average
19.45 visits a year with an average cost of $107.30. When looking specifically at FASD-
related visits, we find that they averaged 7.03 visits per year which accounts for 36% of
all visits but there is considerable variation across ages. We also note that the number of
FASD-related visits increase with age. Additionally, the average costs of an FASD-related
visit is $121.37 which is higher than the average visit of any kind.
Table 3: Frequency of yearly visits and spending by age
Age Frequency Frequency Average charge Average
of visits of FASD visits FASD charge
0 21.37 2.42 395.6 77.71
1 19.66 4.26 95.86 91.29
2 16.37 5.68 68.56 54.58
3 14.68 5.97 65.91 53.35
4 15.17 4.35 64.13 90.30
5 16.89 5.36 59.04 95.10
6 18.04 7.06 61.78 90.99
7 19.01 7.94 63.93 76.44
8 20.72 8.10 70.93 81.62
9 21.44 8.32 75.70 101.98
10 21.29 8.04 87.02 109.20
11 21.08 8.40 91.82 125.31
12 20.76 8.34 105.79 148.91
13 20.14 8.16 104.56 152.69
14 21.42 8.43 114.02 161.63
15 23.19 8.86 137.77 213.75
16 24.72 9.78 159.45 266.24
17 25.19 9.23 170.85 255.58
18 23.90 9.24 157.51 214.20
Average 19.45 7.03 107.30 121.37
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Table 4: Distribution of the number of diagnoses









Table 5: Age at initial diagnosis






















4 Overall spending, FASD-related spending, and visits
First, we ignore initial diagnoses and describe the overall spending and the spending associ-
ated with specific FASD-related visits for all individuals between 2011 and 2015. In Table 6,
we show that the total spending for the 5 years of data is $460 million for the 17,513 individ-
uals who were included between 2011 and 2015. Of that spending, $32.8 million is directly
associated with visits that had a FASD-related code. In Table 7, we break down the FASD-
related spending by diagnosis to better understand where most of this spending is occurring.
In aggregate, attention-deficit/hyperactivity disorder (ADHD) expenditures accounted for
between 23.15% and 40%. Complex trauma accounts for the second highest expenditures.
Table 6: Spending by year
Year All spending Only FASD spending Share attributed to FASD
2011 82,982,136 6,181,993 7.45%
2012 82,146,600 6,552,524 7.98%
2013 96,689,240 6,095,368 6.30%
2014 103,989,048 6,994,743 6.73%
2015 94,708,560.0 6,981,686 7.37%
Total 460,515,584 32,806,315 7.12%
Table 7: Distribution of FASD-related spending by year and diagnostic code
Diagnosis 2011 2012 2013 2014 2015 Total
Attention-deficit/hyperactivity disorder 2,469,104 2,360,382 2,408,326 2,598,420 1,782,780 11,619,012
Complex emotional trauma 1,745,007 2,179,472 1,605,081 1,558,747 2,337,790 9,426,097
Failure to thrive in childhood 265,397 331,256 337,741 1,061,049 392,494 2,387,937
Lack of coordination 346,852 242,123 228,726 303,012 386,268 1,506,981
Reactive attachment disorder 389,211 253,639 231,183 145,505 131,430 1,150,968
Observation for mental condition 144,912 193,321 201,347 173,861 316,071 1,029,512
Delay in development 230,447 175,550 172,570 208,349 179,457 966,373
Feeding difficulty 188,532 190,676 182,932 175,706 139,262 877,108
Cognition-related 2,493 266,693 241,300 171,172 70,136 751,794
Moderate intellectual disabilities 50,392 40,199 137,046 97,197 646,223 971,057
Severe intellectual disabilities 52,954 17,701 100,646 88,956 245,093 505,350
Mild intellectual disabilities 47,475 25,620 26,624 90,455 149,436 339,610
Expressive language disorder 58,778 60,892 41,544 40,979 19,294 221,487
Cognitive disorder, NOS 18,101 35,747 18,810 89,990 9,455 172,103
Delayed milestones 32,705 46,179 39,903 28,158 8,526 155,471
Profound intellectual disabilities 37,515 27,610 21,017 29,888 20,234 136,264
Short stature 23,374 20,580 21,473 23,091 11,676 100,194
Other diagnoses (combined) 78,736 84,875 79,092 110,203 553,577 906,483
6,181,992 6,552,524 6,095,369 6,994,743 6,981,686 32,806,314
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Figure 1: FASD-related expenditures by diagnosis in 2015
In Table 8, we assess the frequency of visits associated with each of the main diagnostic
codes. Unsurprisingly, the two codes responsible for the highest aggregate visits are the ones
with the highest expenditures. This indicates that these codes are very prevalent but not
necessarily the most expensive ones.
Note: While, the most significant overall spending is associated with ADHD, it is simply
due to the high number of individuals who have those visits and not because the visits are
expensive.
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Table 8: Distribution of FASD-related visits by year and diagnosis
Diagnosis 2011 2012 2013 2014 2015
Attention-deficit/hyperactivity disorder 365 365 365 364 273
Complex emotional trauma 364 363 360 363 271
Failure to thrive in childhood 331 340 334 352 268
Reactive attachment disorder 351 338 339 328 261
Delay in development 301 308 309 322 266
Feeding difficulty 284 304 309 334 257
Moderate intellectual disabilities 254 242 310 283 264
Expressive language disorder 283 259 270 265 179
Observation for mental condition 184 240 230 266 232
Delayed milestones 239 263 282 243 116
Mild intellectual disabilities 267 198 181 271 213
Severe intellectual disabilities 180 173 274 227 170
Short stature 174 185 194 202 149
Lack of coordination 147 179 225 223 120
Language disorder 160 188 185 180 157
Severe intellectual disabilities 211 103 138 221 145
Developmental delay 93 173 172 149 55
Delayed milestones 153 132 118 141 98
Post-traumatic stress disorder 108 130 106 151 100
Profound intellectual disabilities 63 82 115 113 88
Short stature 56 76 75 99 82
Mental or behavioral problem 43 50 77 78 72
Disorder of written expression 36 40 57 32 36
Mood disorder 49 34 33 23 47
Mathematics disorder 17 151 6
Observation for other suspected condition 23 40 46 35 28
Hyperkinesis with developmental delay 29 53 57 13 5
Symptoms involving cognition 12 39 56 34 13
Other categories(combined) 78 101 127 150 1,650
All 4,838 4,998 5,361 5,613 5,621
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5 Frequent initial diagnoses
As Table 4 shows, most individuals are included in the dataset due to having only one
FASD-related condition that appears in the available data. We have 14,478 individuals
with one FASD-related diagnosis, 2,285 with 2 diagnoses, 537 individuals with 3 diagnoses,
147 individuals with 4 diagnoses, 42 individuals with 5 diagnoses, 21 individuals with 6
diagnoses, and 3 individuals with 7 diagnoses. Rather than simply examining the visits
and expenditures for the entire sample, we now turn our attention to the initial diagnoses-
inclusion criteria- and how they influence future visits, spending, and general behavior. We
focus on individuals who had only one FASD-related diagnosis to simplify the attribution
process. We see from Table 9 that attention-deficit/hyperactivity disorder is by far the
most prevalent diagnosis (4,405) followed by failure to thrive in childhood (1,942), delay in
development (1,508), and complex emotional trauma (1,064). As we described previously,
there are only 10 people who have an initial diagnosis of fetal alcohol syndrome (FAS). This
means that the majority of our sample has diagnoses that fall under the umbrella of FASDs
but have not been diagnosed with FAS, the most involved form of FASD.
Table 9: Most frequent FASD-related diagnosis for individuals with only one FASD-related
code
Diagnosis Number of individuals
Attention-deficit/hyperactivity disorder 4,405
Failure to thrive in childhood 1,942
Delay in development, unspecified 1,508
Complex emotional trauma (also PTSD) 1,064
Feeding difficulty and mismanagement 798
Expressive language disorder 604
Short stature 519
Problems with communication 516
Delayed milestones 378
Underweight 350
Observation for suspected mental condition 332
Dysmorphic Features 284
Mental or behavioral problem, unspecified 229
Lack of coordination or use for hypotonia (unspecified) 208
Lack of normal physiological development, unspecified 153
Reactive attachment disorder 134
Moderate intellectual disabilities 126
Observation for other suspected condition (neonatal period) 122
Other categories (combined) 806
All 14,478
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5.1 Are there differences in future expenditures based on initial
codes?
Starting with Table 10, we break down the average yearly spending by initial diagnosis.
There is considerable heterogeneity in the amount of money spent on medical visits by
code. We find that the most prevalent diagnoses are not the most expensive ones; for
example, attention-deficit/hyperactivity disorder averages only $5,675 per year while central
nervous system disorder averages $83,484, despite only six individuals diagnosed with it. The
three diagnosis averaging more than $100,000 were severe intellectual disabilities, feeding
difficulties, and lack of normal physiological development. Fetal alcohol syndrome averaged
$4,504.
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Table 10: Average yearly expenditures by initial diagnosis
Diagnostic name 2011 2012 2013 2014 2015
Obs for other condition 30,533 40,614 47,277 222,670 62,751
Mild intellectual disabilities 20,737 12,790 12,710 11,961 11,791
Problems with learning 1,210 737 7,154 5,137 1,127
Problems with communication 5,126 2,243 3,169 4,557 5,161
Mental or behavioral problem 2,525 2,689 2,842 5,570 6,640
Cognitive disorder, NOS 39,487 3,387 15,836 8,498 26,671
Hyperkinesis with dev. delay 10,719 4,605 8,320 2,037 3,131
Disorder of written expression 2,177 1,693 1,820 1,680 1,353
Developmental delay, mixed 40,103 32,027 56,555 39,414 4,002
Delay in Development, unspecified 15,791 12,178 20,566 11,802 12,511
Moderate intellectual disabilities 26,912 20,454 23,433 22,310 19,315
Severe intellectual disabilities 161,437 66,517 36,094 44,841 213,106
Profound intellectual disabilities 116,825 32,257 41,652 38,073 150,090
CNS disorder, NOS 3,508 54,741 109,187 122,548 127,435
Behavioral problems, other 1,651 1,262 2,358 1,564 1,180
Obs for suspected mental condition 7,386 5,483 6,452 6,837 17,454
Maternal complication 1,849 1,485 3,461 1,548 4,957
Lack of coordination 88,394 22,146 127,741 109,314 40,858
Feeding difficulty 126,757 92,183 151,612 101,791 185,549
Dysmorphic Features 45,217 9,764 9,586 24,758 10,573
Mood disorder 3,905 4,652 4,534 10,224 4,126
Complex emotional trauma 8,298 10,102 11,051 10,940 11,030
Intermittent explosive disorder 15,312 33,355 8,686 48,404 33,148
Academic underachievement 1,588 1,705 1,234 5,980 3,554
Reactive attachment disorder 7,499 6,565 8,672 11,760 6,985
ADD 12,708 11,484 6,390 7,658 5,059
ADHD 5,579 5,231 5,345 6,359 5,861
Intro Procedures on the Larynx 3,676 3,689 2,382 2,108 2,308
Alexia 3,204 712 189 223
Developmental dyslexia 1,691 1,310 1,412 964 689
Specific reading disorder 1,597 5,593 1,463 960 1,020
Expressive language disorder 4,376 1,969 4,096 1,943 4,681
Language disorder 18,074 2,474 2,515 6,735 2,132
Mild cognitive impairment 1,679 2,097 7,176 5,485 5,582
Toxic encephalopathy 1,341 2,590 88,863 36,921
Static encephalopathy 5,090 17,944 21,321 2,920 22,166
Microphthalmos NOS 23,946 96,402 20,833 15,975 10,283
Fetal Alcohol Syndrome (EIU) 3,465 2,377 4,845 2,163 9,669
Underweight 5,223 2,948 1,738 2,092 1,828
Lack norm physio dev NOS 74,662 312,012 80,336 78,569 84,524
Failure to thrive in childhood 14,749 12,532 15,159 16,432 44,790
Delayed milestones 14,533 31,810 3,561 11,035 2,858
Short stature 9,358 6,313 9,764 7,189 31,223
Alexia and dyslexia 786 566 3,502 1,433 1,193
Symbolic dysfunction 865 680 610 833 824
Cognitive communication deficit 294 3,889 2,110 451 850
Symptoms involving cognition 9,437 9,932 159,022 88,341 21,189
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Figure 2: Distribution of total spending between 2011 and 2015
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Figure 3: Distribution of total visits
6 Distribution of spending and visits at the individual
level
As we have shown above, there is considerable heterogeneity in spending and visits by initial
code. This section describes the distribution of spending and visits at the individual level.
Figure 2 shows that the average expenditure at the individual level is $26,295 but with a
large standard deviation of $118,473 which makes it clear that the data is highly skewed.
In fact, at $4,865, the median expenditure is considerably lower than the average. Most of
the individuals (75%) had expenditures less than $10,703. This finding is consistent when
examining the number of visits, as the average is much higher than the median as can be
seen in Figure 3.
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7 Who is responsible for the spending?
This section shows that almost 86% of the spending is attributable to the top 20% individuals.
The lowest 20% spenders are responsible for less than 1% of the overall expenditures.
(1)












Standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
Figure 4: Share of spending by quintile
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8 Basic estimation
In this section, we examine the factors that explain the variation in expenditures across
individuals. We estimate the basic regression below as a starting point:
yi = β0 + β1Diagi + β2Male+ β3Age+ β4Agesq + τt + εi (1)
where yi is the total spending for individual i; Diagi are the total number of orignial diagnoses
for individual i; Male is a dummy variable indicating if the patient is male or female, Age
and Age squared examine the nonlinear relationship between age and expenditures. Lastly,
τ captures time invariant effects, and εi is the model error. The β1−4 and τ coefficients are
parameters to be estimated. The coefficient of interest, β1, is the estimated effect of an
additional diagnosis on expenditures.
(1)
VARIABLES Total spending





















Standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
From the regression, we can conclude that each additional FASD-related diagnosis is
associated with an additional $44,825 in expenditures. It is important to note that the
majority of individuals in our sample have only 1 FASD-related diagnosis. Additionally,
we can see that, holding all other variables constant, being a male is associated with fewer
expenditures and a diagnosis at an earlier age is also associated with less spending.
9 Births post 2010
In this section, we focus on individuals born post 2010. Since the available data begins in
2011, examination of these individuals allows us to observe the universe of their visits. This
simplifies our analysis as we do not have any omitted visits before the start of our data.
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When we restrict our data to just those individuals, we are left with 3,896 individuals with
a total of 457,820 observations. Of the individuals, 57.2% are male and 42.8% are female.
For this subsample, the first 1-5 years of life are captured in the data and, over that time,
these children have an average of 60 visits per year with an average visit cost of $410.60.
Table 11: Number of individuals by race and gender
Race Female Male Total
Native Hawaian 254 365 619
Filipino 284 386 670
Pacific Islander 139 202 341
Other Asian 188 295 483
White 294 380 674
Other 337 418 755
Unknown 162 183 345
Total 1,658 2,229 3,887
In Table 12, we show the distribution of the births across the five years for which we have
data. We observe the children who were born in 2011 years for four years, those in 2012 for
3 years, and so on.
Table 12: Number of children by birth year







For an individual to be included in our dataset, they have to meet an inclusion criteria of
having at least one FASD-related visit. The table below shows the age at which the children
first had an FASD-related visit. We can see that, in this subsample of individuals born after
2010, 35.9% of the individuals had their first diagnosis before turning 1 and 81.7% of our
sample had an FASD-related visit by the age of 3.
9.1 When does the initial diagnosis happen?
We examine the number of FASD-related conditions for the children in our subsample in
Table 14. We find that the majority (82.4%) have only one FASD-related condition; less
than 0.6% have more than 5 conditions. We next examine the frequency of overall and
FASD-specific visits. We note from the table that the share of visits specifically associated
with FASD-related conditions differ by age and range between 7.1% and 12.5%.
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Table 13: Age of initial diagnosis







Table 14: Inclusion criteria








9.2 Frequency of visits
Table 15: Visits and expenditures by age
Age M visits M FASD-related visits M charges M FASD-related charges
0 21.37 2.42 395.60 77.71
1 20.16 4.24 98.83 97.31
2 16.53 5.49 68.19 50.95
3 14.82 5.90 66.32 56.92
4 14.96 6.01 58.97 43.80
Overall 18.47 4.15 166.97 73.27
9.3 Visits and spending by year at the individual level
In this section, we analyze the information at the individual level by averaging the spending
by year. Therefore, we only leave one observation per year per individual.
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Table 16: Total and FASD expenditures by year
Year M per visit SD per visit M total SD total
Expenditures by year at the individual level
2011 227.87 503.04 15,583.42 61,772.4
2012 191.74 525.33 13,697 103,124
2013 181.83 738.98 14,435.06 79,547.01
2014 172.32 708.58 15,055.51 78,044.97
2015 114.26 403.26 12,023.13 86,807.3
Average 166.97 604.41 10,671.41 73,873.39
FASD expenditures by year at the individual level
2011 79.09 223.00 172.47 380.00
2012 79.14 456.12 346.88 1,732.10
2013 59.30 107.15 356.98 2,647.35
2014 73.95 438.26 774.83 12,616.75
2015 79.90 1,022.43 415.51 2,662
Average 73.27 597.15 471.97 6,952.01
Table 17: Overall and FASD-related visits by year
Year M visits SD visits M FASD visits SD FASD visits
2011 17.53 24.10 4.87 9.05
2012 17.72 24.67 4.37 8.24
2013 18.55 25.32 4.22 7.73
2014 18.96 28.56 4.29 8.37
2015 18.67 30.90 4.28 8.54
Average 18.47 27.56 4.28 8.27
Table 18: Overall expenditures by year








10 Who is responsible for the spending among the chil-
dren born post 2010?
This section shows that almost 90% of the spending is attributable to top 20% of individuals.















Standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
Figure 5: Figure 4: Who is responsible for the spending?
10.1 Are the results any different for this subsample?
The results for the children born post 2010 are very similar to our main analysis. This
consistency gives us confidence in our main sample.
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11 Limitations
Findings of these analyses must be interpreted in context of the study’s limitations. First,
the data available include patients who met inclusion criteria within seven years. Therefore,
other patients who had FASD-related diagnoses outside of the seven year window are not
included. Additionally, the data are for visits during a five year period and therefore do not
capture the entire adolescent period from birth through age 18 for any cohort of patients.
A second limitation is related to the challenges of diagnosing FASDs. As an umbrella
diagnosis, FASDs includes many conditions and the data available are based on ICD codes
that relate to those specific conditions. However, these conditions are not always FASD and
there is not a unique ICD code for the conditions when they represent FASD. Therefore, it is
likely that not all of the patients included in our analyses have a FASD. Approximately 9% of
Hawaii’s childhood Medicaid population is included in our sample and 5% is a conservative
estimate of FASD prevalence. Therefore, we are likely slightly overestimating the visits and
expenditures that are truly associated with FASDs. However, FASDs tend to be complex
disorders, which suggests that the more expensive cases may be more likely to be attributable
to FASDs.
12 What does FASD prevention cost?
FASDs are preventable if a developing fetus is not exposed to alcohol. Alcohol SBI is an
evidence-based approach to reduce risky alcohol use and prevent consequences of risky alcohol
use, including FASDs.
As 45.2% of Hawaii births are unintended (Centers for Disease Control and Prevention,
2011), prevention efforts should focus on all women who could become pregnant, not just
those are trying to become pregnant. Hawaii has 261,665 females ages 15-44 (U.S. Census
Bureau, 2010). Of those, 18%, or 47,100 people, are covered by Medicaid (Guttmacher,
2018). Prevention for FASDs could focus on women who drink alcohol, which is 41% of
women in Hawaii (BRFSS, 2011-2014), or 19,311 women of childbearing age on Medicaid.
Hawaii Medicaid reimbursement rates for alcohol SBI are $24.04 (15-30 minutes) and $46.92
(more than 30 minutes). Even if every woman of childbearing age who drinks alcohol is given
a brief intervention, it would cost $464,236. This is an overestimate of costs of prevention, as
most women who consume alcohol do not require a 15-minute brief intervention and instead
could be educated about the risks of alcohol during pregnancy with a briefer amount of
discussion and education.
13 Conclusion
We found that, on average, FASD-related visits cost Medicaid $6 million/year in Hawaii.
Some, but not all, of these costs can be prevented by reducing alcohol-exposed pregnancies.
Alcohol SBI can be used systematically and cost-effectively to prevent FASDs as well as other
consequences of risky alcohol use. Alcohol SBI consultations are currently reimbursed only
when they are at least 15 minutes, but it typically takes only 3-4 minutes. Medicaid in Hawaii
and other states could promote prevention of FASDs through improved reimbursement rates
22
and reimbursement for briefer (less than 15 minute) interventions. Even if Medicaid incurred
additional costs for alcohol SBI, such prevention activities are far less expensive than treating
alcohol consequences including FASDs.
23
References
Babor, T. F., B. G. McRee, P. A. Kassebaum, P. L. Grimaldi, K. Ahmed, and J. Bray (2007).
Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health
approach to the management of substance abuse. Substance abuse 28 (3), 7–30.
Chasnoff, I. J., A. M. Wells, and L. King (2015, 2). Misdiagnosis and Missed Diagnoses in
Foster and Adopted Children With Prenatal Alcohol Exposure. PEDIATRICS 135 (2),
264–270.
Désy, P. M. and C. Perhats (2008, 2). Alcohol Screening, Brief Intervention, and Refer-
ral in the Emergency Department: An Implementation Study. Journal of Emergency
Nursing 34 (1), 11–19.
Hong, M. and R. S. Krauss (2017, 4). Ethanol itself is a holoprosencephaly-inducing terato-
gen. PLoS ONE 12 (4).
Jirikowic, T., J. Gelo, and S. Astley (2010, 10). Children and youth with fetal alcohol
spectrum disorders: Summary of intervention recommendations after clinical diagnosis.
Intellectual and Developmental Disabilities 48 (5), 330–344.
Lange, S., C. Probst, G. Gmel, J. Rehm, L. Burd, and S. Popova (2017, 10). Global
prevalence of fetal alcohol spectrum disorder among children and youth: A systematic
review and meta-analysis. JAMA Pediatrics 171 (10), 948–956.
Lewis, V. A., C. H. Colla, K. Tierney, A. D. van Citters, E. S. Fisher, and E. Meara (2014).
Few ACOs pursue innovative models that integrate care for mental illness and substance
abuse with primary care. Health Affairs 33 (10), 1808–1816.
May, P. A., C. D. Chambers, W. O. Kalberg, J. Zellner, H. Feldman, D. Buckley, D. Kopald,
J. M. Hasken, R. Xu, G. Honerkamp-Smith, H. Taras, M. A. Manning, L. K. Robin-
son, M. P. Adam, O. Abdul-Rahman, K. Vaux, T. Jewett, A. J. Elliott, J. A. Kable,
N. Akshoomoff, F. Daniel, J. A. Arroyo, D. Hereld, E. P. Riley, M. E. Charness, C. D.
Coles, K. R. Warren, K. L. Jones, and H. E. Hoyme (2018, 2). Prevalence of fetal alco-
hol spectrum disorders in 4 US communities. JAMA - Journal of the American Medical
Association 319 (5), 474–482.
Onoye, J. M. and M. D. Thompson (2017, 5). Challenges and Progress in Building a Com-
prehensive Statewide System for Fetal Alcohol Spectrum Disorders Prevention in Hawaii.
Maternal and Child Health Journal 21 (5), 1002–1009.
Popova, S., S. Lange, C. Probst, G. Gmel, and J. Rehm (2017, 3). Estimation of national,
regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome:
a systematic review and meta-analysis. The Lancet Global Health 5 (3), e290–e299.
Popova, S., S. Lange, K. Shield, A. Mihic, A. E. Chudley, R. A. Mukherjee, D. Bekmuradov,
and J. Rehm (2016, 3). Comorbidity of fetal alcohol spectrum disorder: A systematic
review and meta-analysis. The Lancet 387 (10022), 978–987.
24
Rieckmann, T., S. Renfro, D. McCarty, R. Baker, and K. J. McConnell (2018, 6). Quality
Metrics and Systems Transformation: Are We Advancing Alcohol and Drug Screening in
Primary Care? Health Services Research 53 (3), 1702–1726.
25
